Pacira Pharma Cash Flow - Annual (NASDAQ:PCRX)

Add to My Stocks
$51.35 $3.5 (7.31%) PCRX stock closing price Sep 19, 2018 (Closing)

The Pacira Pharma cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Pacira Pharma profits and Pacira Pharma debt. Pacira Pharma cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. Pacira Pharma had cash and cash equivalents of $35.94M at the beginning of the year and $54.12M at year end for 2017. The cash from operating activities for Pacira Pharma is $ 2017, which saw a decrease from previous year.

View details of Pacira Pharma cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow25.5M17.48M16.05M14.66M10.16M6.24M5.87M4.25M4.43M3.83M
Net Increase (Decrease) in Assets Liabilities-2.57M22.27M-22.34M-0.45M-4.41M-29.92M--2.01M4.2M8.17M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net37.46M31.63M33.42M24.98M14.94M5.83M5.78M-2.23M-
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-19.26M-24.7M-41.27M-21.88M-12.79M-18.25M-6.15M-6.76M-5.5M-5.83M
Acquisition Disposition of Subsidiaires-8.46M-15.85M-7.11M-13.43M-2.03M-10.33M----
Increase (Decrease) in Investments-196.03M-21.18M28.15M-84.01M-28.73M-0.92M-29.97M---
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares8.64M7.26M12.16M118.87M3.85M63.72M87.15M--40.17M
Issuance (Repayment) of Debt Securities226.8M--1.46M-92.5M1.25M-52.5M21.25M-
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-11.28M----7.19M-1.36M--1.79M-0.21M-
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year35.94M56.98M37.52M12.51M10.12M46.16M26.13M7.07M12.38M7.24M
Cash & Equivalents at Year End54.12M35.94M56.98M37.52M12.51M10.12M46.16M26.13M7.07M12.38M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Pacira Pharma stock price history and Pacira Pharma stock comparison chart inevitably reflect its cash flow situation.

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Pacira Pharma is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Pacira Pharma stock price movement.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a positive value of $17.78M for PCRX.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-223.76M for PCRX stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $224.16M for Pacira Pharma.

Key Financial Ratios For Pacira Pharma Cash Flow

FCF margin